Cargando…
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
Medulloblastoma (MB) is the most common malignant childhood tumor of the brain. Multimodal treatment consisting of surgery, radiation therapy, and chemotherapy reduced cumulative incidence of late mortality but increased the incidence of subsequent neoplasms and severe, incapacitating chronic health...
Autores principales: | Menyhárt, Otília, Győrffy, Balázs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098941/ https://www.ncbi.nlm.nih.gov/pubmed/31970590 http://dx.doi.org/10.1007/s10555-020-09854-1 |
Ejemplares similares
-
Principles of tumorigenesis and emerging molecular drivers of SHH‐activated medulloblastomas
por: Menyhárt, Otília, et al.
Publicado: (2019) -
Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas
por: Menyhárt, Otília, et al.
Publicado: (2019) -
Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis
por: Menyhárt, Otília, et al.
Publicado: (2021) -
Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies
por: Menyhárt, Otília, et al.
Publicado: (2021) -
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
por: Menyhárt, Otília, et al.
Publicado: (2018)